Literature DB >> 1351921

Murine thymic CD4+ T cell subsets: a subset (Thy0) that secretes diverse cytokines and overexpresses the V beta 8 T cell receptor gene family.

K Hayakawa1, B T Lin, R R Hardy.   

Abstract

We demonstrate here the presence of a distinct mature CD4+8- T cell subset in mouse thymus. This subset, termed "Thy0," is delineated by the absence of 3G11 expression from about half of the 6C10-/HSAlow/- fraction of CD4+8- thymic cells. Thy0 is detectable from the neonatal period and largely contributes the Th0-type diverse cytokine production previously reported for the HSAlow/-CD4+ thymic population. Further, cells expressing the T cell receptor V beta 8 gene family are found at increasing frequency in Thy0 with age, comprising 40-60% of Thy0 in adult BALB/c mice. This alteration of V beta 8+ cell frequency is unique to Thy0, since no other CD4+ subset in thymus or spleen shows such V beta 8 overusage. All functional CD4+ T cell subsets, including Thy0, show appropriate V beta clonal deletion associated with endogenous superantigens. Thus, it appears that Thy0 is an intrathymically generated secondary cell subset produced after CD4+ T cell selection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351921      PMCID: PMC2119274          DOI: 10.1084/jem.176.1.269

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Specific assays for cytokine production by T cells.

Authors:  T R Mosmann; T A Fong
Journal:  J Immunol Methods       Date:  1989-01-17       Impact factor: 2.303

2.  Expression of an unusual T cell receptor (TCR)-V beta repertoire by Ly-6C+ subpopulations of CD4+ and/or CD8+ thymocytes. Evidence for a developmental relationship between Ly-6C+ thymocytes and CD4-CD8-TCR-alpha beta+ thymocytes.

Authors:  Y Takahama; S O Sharrow; A Singer
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

3.  Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes.

Authors:  P J Dyson; A M Knight; S Fairchild; E Simpson; K Tomonari
Journal:  Nature       Date:  1991-02-07       Impact factor: 49.962

4.  V beta gene polymorphism and a major polyclonal T cell receptor idiotype.

Authors:  G K Sim; A A Augustin
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

5.  Phenotype, ontogeny, and repertoire of CD4-CD8- T cell receptor alpha beta + thymocytes. Variable influence of self-antigens on T cell receptor V beta usage.

Authors:  Y Takahama; A Kosugi; A Singer
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

6.  Murine T-cell receptor mutants with deletions of beta-chain variable region genes.

Authors:  M A Behlke; H S Chou; K Huppi; D Y Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

7.  Molecular characterization of T-cell antigen receptor expression by subsets of CD4- CD8- murine thymocytes.

Authors:  M Pearse; P Gallagher; A Wilson; L Wu; N Fisicaro; J F Miller; R Scollay; K Shortman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Subpopulations of mature murine thymocytes: properties of CD4-CD8+ and CD4+CD8- thymocytes lacking the heat-stable antigen.

Authors:  A Wilson; L M Day; R Scollay; K Shortman
Journal:  Cell Immunol       Date:  1988-12       Impact factor: 4.868

9.  Murine CD4+ T cell subsets defined.

Authors:  K Hayakawa; R R Hardy
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

10.  Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocytes.

Authors:  R C Budd; G C Miescher; R C Howe; R K Lees; C Bron; H R MacDonald
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

View more
  29 in total

Review 1.  The ins and outs of type I iNKT cell development.

Authors:  Susannah C Shissler; Tonya J Webb
Journal:  Mol Immunol       Date:  2018-11-28       Impact factor: 4.407

2.  Type II NKT cells facilitate Alum-sensing and humoral immunity.

Authors:  Hemangi B Shah; T Scott Devera; Pragya Rampuria; Gillian A Lang; Mark L Lang
Journal:  J Leukoc Biol       Date:  2012-07-13       Impact factor: 4.962

Review 3.  The role of invariant T cells in inflammation of the skin and airways.

Authors:  Kwok Ho Yip; Magdalene Papadopoulos; Harshita Pant; Damon J Tumes
Journal:  Semin Immunopathol       Date:  2019-04-15       Impact factor: 9.623

4.  Transient control of interleukin-4-producing natural killer T cells in the livers of Listeria monocytogenes-infected mice by interleukin-12.

Authors:  Y Emoto; M Emoto; S H Kaufmann
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

Review 5.  The role of NKT cells in tumor immunity.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

Review 6.  Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants.

Authors:  Sungjune Kim; Saif Lalani; Vrajesh V Parekh; Lan Wu; Luc Van Kaer
Journal:  Expert Rev Vaccines       Date:  2008-12       Impact factor: 5.217

7.  Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.

Authors:  Ivan J Fuss; Frank Heller; Monica Boirivant; Francisco Leon; Masaru Yoshida; Stefan Fichtner-Feigl; Zhiqiong Yang; Mark Exley; Atsushi Kitani; Richard S Blumberg; Peter Mannon; Warren Strober
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

8.  Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4.

Authors:  T Yoshimoto; A Bendelac; J Hu-Li; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

9.  Natural killer T cells subsets in cancer, functional defects in prostate cancer and implications for immunotherapy.

Authors:  Michael Nowak; Ingo G H Schmidt-Wolf
Journal:  Cancers (Basel)       Date:  2011-09-20       Impact factor: 6.639

10.  Interleukin 7 induces preferential expansion of V beta 8.2+CD4-8- and V beta 8.2+CD4+8- murine thymocytes positively selected by class I molecules.

Authors:  A Vicari; M do C de Moraes; J M Gombert; M Dy; C Penit; M Papiernik; A Herbelin
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.